Alpha-arylethylpiperazine derivatives as neurokinin antagonists
The invention relates to new -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK 1 antagonists). It also relates to processes for the preparation of said -arylethylpiperazine derivatives, to their use for the prevention and/or treatment of a condition associated...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Stiernet, Francoise Genicot, Christophe Lassoie, Marie-Agnes Moureau, Florence Ryckmans, Thomas Taverne, Thierry Henichart, Jean-Pierre Neuwels, Michel Goldstein, Solo |
| description | The invention relates to new -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK
1
antagonists). It also relates to processes for the preparation of said -arylethylpiperazine derivatives, to their use for the prevention and/or treatment of a condition associated with pathogical levels of substance P in a patient and to pharmaceutical compositions containing them. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20030220323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20030220323</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200302203233</originalsourceid><addsrcrecordid>eNqVzDEKAkEMQNFpLES9w7QWC8PMAURkxQPYL0GjGwyZMMkurKfXwgtY_ebx1-FwZB2hg7Yw-riwkmKDNwnGOzaawWlGi2BRcGr1RUISQRyeVcjctmH1ADbc_boJ-3N_PV26yRQcxW0AVabbd1TFhpxSSTmnkkv5x34A6VU5Jw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Alpha-arylethylpiperazine derivatives as neurokinin antagonists</title><source>USPTO Published Applications</source><creator>Stiernet, Francoise ; Genicot, Christophe ; Lassoie, Marie-Agnes ; Moureau, Florence ; Ryckmans, Thomas ; Taverne, Thierry ; Henichart, Jean-Pierre ; Neuwels, Michel ; Goldstein, Solo</creator><creatorcontrib>Stiernet, Francoise ; Genicot, Christophe ; Lassoie, Marie-Agnes ; Moureau, Florence ; Ryckmans, Thomas ; Taverne, Thierry ; Henichart, Jean-Pierre ; Neuwels, Michel ; Goldstein, Solo</creatorcontrib><description>The invention relates to new -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK
1
antagonists). It also relates to processes for the preparation of said -arylethylpiperazine derivatives, to their use for the prevention and/or treatment of a condition associated with pathogical levels of substance P in a patient and to pharmaceutical compositions containing them.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20030220323$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,873,885,64059</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/10168331$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Stiernet, Francoise</creatorcontrib><creatorcontrib>Genicot, Christophe</creatorcontrib><creatorcontrib>Lassoie, Marie-Agnes</creatorcontrib><creatorcontrib>Moureau, Florence</creatorcontrib><creatorcontrib>Ryckmans, Thomas</creatorcontrib><creatorcontrib>Taverne, Thierry</creatorcontrib><creatorcontrib>Henichart, Jean-Pierre</creatorcontrib><creatorcontrib>Neuwels, Michel</creatorcontrib><creatorcontrib>Goldstein, Solo</creatorcontrib><title>Alpha-arylethylpiperazine derivatives as neurokinin antagonists</title><description>The invention relates to new -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK
1
antagonists). It also relates to processes for the preparation of said -arylethylpiperazine derivatives, to their use for the prevention and/or treatment of a condition associated with pathogical levels of substance P in a patient and to pharmaceutical compositions containing them.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNqVzDEKAkEMQNFpLES9w7QWC8PMAURkxQPYL0GjGwyZMMkurKfXwgtY_ebx1-FwZB2hg7Yw-riwkmKDNwnGOzaawWlGi2BRcGr1RUISQRyeVcjctmH1ADbc_boJ-3N_PV26yRQcxW0AVabbd1TFhpxSSTmnkkv5x34A6VU5Jw</recordid><startdate>20031127</startdate><enddate>20031127</enddate><creator>Stiernet, Francoise</creator><creator>Genicot, Christophe</creator><creator>Lassoie, Marie-Agnes</creator><creator>Moureau, Florence</creator><creator>Ryckmans, Thomas</creator><creator>Taverne, Thierry</creator><creator>Henichart, Jean-Pierre</creator><creator>Neuwels, Michel</creator><creator>Goldstein, Solo</creator><scope>EFI</scope></search><sort><creationdate>20031127</creationdate><title>Alpha-arylethylpiperazine derivatives as neurokinin antagonists</title><author>Stiernet, Francoise ; Genicot, Christophe ; Lassoie, Marie-Agnes ; Moureau, Florence ; Ryckmans, Thomas ; Taverne, Thierry ; Henichart, Jean-Pierre ; Neuwels, Michel ; Goldstein, Solo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200302203233</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Stiernet, Francoise</creatorcontrib><creatorcontrib>Genicot, Christophe</creatorcontrib><creatorcontrib>Lassoie, Marie-Agnes</creatorcontrib><creatorcontrib>Moureau, Florence</creatorcontrib><creatorcontrib>Ryckmans, Thomas</creatorcontrib><creatorcontrib>Taverne, Thierry</creatorcontrib><creatorcontrib>Henichart, Jean-Pierre</creatorcontrib><creatorcontrib>Neuwels, Michel</creatorcontrib><creatorcontrib>Goldstein, Solo</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Stiernet, Francoise</au><au>Genicot, Christophe</au><au>Lassoie, Marie-Agnes</au><au>Moureau, Florence</au><au>Ryckmans, Thomas</au><au>Taverne, Thierry</au><au>Henichart, Jean-Pierre</au><au>Neuwels, Michel</au><au>Goldstein, Solo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Alpha-arylethylpiperazine derivatives as neurokinin antagonists</title><date>2003-11-27</date><risdate>2003</risdate><abstract>The invention relates to new -arylethylpiperazine derivatives, which are useful as neurokinin receptor antagonists (NK
1
antagonists). It also relates to processes for the preparation of said -arylethylpiperazine derivatives, to their use for the prevention and/or treatment of a condition associated with pathogical levels of substance P in a patient and to pharmaceutical compositions containing them.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_applications_20030220323 |
| source | USPTO Published Applications |
| title | Alpha-arylethylpiperazine derivatives as neurokinin antagonists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T01%3A17%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Stiernet,%20Francoise&rft.date=2003-11-27&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20030220323%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |